![POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies - ScienceDirect POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378111916304942-gr2.jpg)
POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies - ScienceDirect
![DNA Polymerase Delta 1 Catalytic Subunit (POLD1) as a Prognostic Factor in Clear Cell Renal Cell Carcinoma Patients | In Vivo DNA Polymerase Delta 1 Catalytic Subunit (POLD1) as a Prognostic Factor in Clear Cell Renal Cell Carcinoma Patients | In Vivo](https://iv.iiarjournals.org/content/invivo/36/3/1188/F2.large.jpg)
DNA Polymerase Delta 1 Catalytic Subunit (POLD1) as a Prognostic Factor in Clear Cell Renal Cell Carcinoma Patients | In Vivo
![What is POLD1 Gene Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome NGS Genetic DNA Test ? What is POLD1 Gene Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome NGS Genetic DNA Test ?](https://dnalabsindia.com/uploads/images/60b1d0640fe62.jpg)
What is POLD1 Gene Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome NGS Genetic DNA Test ?
![Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor. - Abstract - Europe PMC Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7867935/bin/atm-09-02-129-f2.jpg)
Distinctive genomic characteristics in POLE/POLD1-mutant cancers can potentially predict beneficial clinical outcomes in patients who receive immune checkpoint inhibitor. - Abstract - Europe PMC
![Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing | BMC Genomics | Full Text Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing | BMC Genomics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12864-023-09310-8/MediaObjects/12864_2023_9310_Fig1_HTML.png)
Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing | BMC Genomics | Full Text
Exome sequencing reveals a de novo POLD1 mutation causing phenotypic variability in mandibular hypoplasia, deafness, progeroid f
![POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies | Semantic Scholar POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0a1c4a187e7e929cdf16ce37e7e475045a9ffab2/6-Figure3-1.png)
POLD1: Central mediator of DNA replication and repair, and implication in cancer and other pathologies | Semantic Scholar
![High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation.,Modern Pathology - X-MOL High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation.,Modern Pathology - X-MOL](https://xpic.x-mol.com/20191221%2F10.1038_s41379-019-0430-6.png)
High mutational burden in colorectal carcinomas with monoallelic POLE mutations: absence of allelic loss and gene promoter methylation.,Modern Pathology - X-MOL
Assessment of POLE and POLD1 mutations as prognosis and immunotherapy biomarkers for stomach adenocarcinoma
![Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.,Scientific Reports - X-MOL Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.,Scientific Reports - X-MOL](https://xpic.x-mol.com/20191101%2F10.1038_s41598-019-52414-z.jpg)
Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population.,Scientific Reports - X-MOL
![POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text POLE/POLD1 mutation and tumor immunotherapy | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-022-02422-1/MediaObjects/13046_2022_2422_Fig2_HTML.png)